Episode #145. Cancer Isn’t One Size Fits All, Why Treatment Shouldn’t Be Either, with Jim Foote, CEO and Co-Founder of First Ascent Biomedical

What if cancer treatment could be as unique as your own DNA?

In this episode, Jim Foote, CEO and Co-Founder of First Ascent Biomedical, shares how his company is transforming oncology through functional precision medicine, designing personalized cancer treatments tailored to each patient’s biology. He explains how this approach moves beyond population averages to improve outcomes and why technology and biology must work together to guide care. Foote also reflects on how losing his 17-year-old son to cancer inspired him to create better tools for doctors and patients alike, comparing cancer’s constant mutation to the evasiveness of cyber threats.

Tune in to hear how innovation, resilience, and data-driven care are redefining the future of cancer treatment!

For more information and ways to increase risk awareness and safety, visit us at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.censinet.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Music by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠David Cosgrove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ an accomplished composer, musician, producer, and engineer. Listen to his latest project ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Del Piombo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.